Package 63629-4866-2

{"route": ["ORAL"], "spl_id": "3511b6fb-ead0-43db-ba3e-15dff208f04b", "openfda": {"nui": ["N0000175428", "N0000175448"], "unii": ["668Z8C33LU"], "rxcui": ["200257"], "spl_set_id": ["3b150917-e2fd-4366-af83-ebc1d7297ca9"], "pharm_class_epc": ["Glinide [EPC]"], "pharm_class_moa": ["Potassium Channel Antagonists [MoA]"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (63629-4866-1)", "package_ndc": "63629-4866-1", "marketing_start_date": "20250116"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (63629-4866-2)", "package_ndc": "63629-4866-2", "marketing_start_date": "20250116"}], "brand_name": "Repaglinide", "product_id": "63629-4866_3511b6fb-ead0-43db-ba3e-15dff208f04b", "dosage_form": "TABLET", "pharm_class": ["Glinide [EPC]", "Potassium Channel Antagonists [MoA]"], "product_ndc": "63629-4866", "generic_name": "Repaglinide", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Repaglinide", "active_ingredients": [{"name": "REPAGLINIDE", "strength": ".5 mg/1"}], "application_number": "ANDA203820", "marketing_category": "ANDA", "marketing_start_date": "20140122", "listing_expiration_date": "20261231"}